Allosteric inhibition of SHP2 induces antitumor immunity in PD-1-sensitive tumors through modulation of both innate and adaptive mechanisms

Elsa Quintana, Kasia Mordec, Robert J. Nichols, David Wildes, Christopher J. Schulze, Darienne R. Myers, Mallika Singh, Elena S. Koltun, Adrian L. Gill, Steve Kelsey, Mark A. Goldsmith, Jacqueline A. M. Smith


Fourth CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference: Translating Science into Survival; 30 Sep to 3 Oct 2018; New York, NY.  Poster A103.


Return to Media Home